Events | 2020.08.19
Regeneron and Roche Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Cocktail for COVID-19
TARRYTOWN, N.Y., Aug. 19, 2020 /PRNewswire/ -- REGN-COV2 is Regeneron\'s two-antibody \'cocktail\' currently in late-stage clinical trials for the treatment and prevention of COVID-19 infection The companies will collaborate on developing and manufacturing REGN-COV2; Regeneron will...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]il-for-covid-19-301114443.html
